Amylin Pharmaceuticals, Inc. (AMLN) – Analyst EPS View
-
Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect
-
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Back to AMLN Stock Lookup